![]() |
市場調查報告書
商品編碼
1828174
2025年全球胸骨閉合系統市場報告Sternal Closure Systems Global Market Report 2025 |
近年來,胸骨閉合系統市場穩定成長,預計2024年將達到23.4億美元,2025年將達到24.3億美元,複合年成長率為4.0%。預測期內的成長歸因於心血管手術的增加、心血管疾病的流行、對胸骨併發症認知的提高、外科醫生與設備製造商之間的合作以及對微創心血管手術的關注。
預計未來幾年胸骨閉合系統市場將強勁成長,到2029年將達到30.7億美元,複合年成長率為6.0%。預測期內的成長可歸因於微創手術的快速成長、對以患者為中心的醫療保健的日益重視、新興市場心臟手術的擴張、對減少術後併發症的重視以及研發合作。預測期內的主要趨勢包括器械材料的創新、手術技術的進步、微創方法、胸骨固定技術、無線遠端監控、客製化以及針對特定患者的解決方案。
胸骨閉合系統是用於牢固閉合胸骨(保護心臟和肺部的胸部中央骨骼)的醫療設備或方法。這些系統在閉合胸腔時起著至關重要的作用,因為在心血管手術或其他需要進入胸腔的手術中,胸腔可能會打開。
胸骨閉合系統的主要產品類型是閉合裝置和骨水泥,用於正中胸骨切開術、半胸骨切開術和雙側胸骨切開術等手術。胸骨閉合裝置經過特殊設計,可在癒合過程中穩定胸骨,降低併發症風險並促進更快康復。這些裝置用於開胸手術後閉合胸骨。胸骨閉合系統常用的材料包括鈦、聚醚醚酮 (PEEK) 和不銹鋼。這些系統廣泛應用於各種醫療機構,包括醫院、診所、研究機構和其他醫療機構。
2025年,美國關稅的大幅上調及其引發的貿易摩擦將對醫療設備產業產生重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品的影響。由於醫院和診所抵制價格上漲,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要醫療設備重新認證,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新研究報告系列的一部分,該系列提供了胸骨閉合系統的市場統計數據,包括全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的胸骨閉合系統細分市場、市場趨勢和商業機會,以及在胸骨閉合系統行業取得成功所需的其他數據。這份胸骨閉合系統市場研究報告對該行業的現狀和未來趨勢進行了詳細分析,為您提供所需的全面觀點。
未來五年6.0%的預測成長率,較我們先前對該市場的預測略有下降,下降了0.3%。下降的主要原因是美國與其他國家之間關稅的影響。這一影響將直接影響美國,導致鈦電鍍系統和胸骨絲合金等關鍵部件的供應鏈中斷,這些部件來自瑞典、比利時和新加坡等主要地區,可能導致心血管手術延誤和成本增加。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,這一影響也將更為廣泛地顯現。
預計胸骨閉合市場的成長將受到慢性病盛行率上升的推動。慢性病的特徵是病程持續一年以上,需要持續的醫療護理,通常需要外科手術干預,例如冠狀動脈繞道手術術 (CABG) 和瓣膜置換術術。這些手術需要胸骨切開術,因此有效的胸骨閉合至關重要。例如,根據美國美國衛生研究院 (NIH) 的報告,預計到 2050 年,美國50 歲及以上患有至少一種慢性病的人數將從 2020 年的 71,522,000 人增加 99.5% 至 142,660,000 人。此外,預計到 2050 年,患有多種疾病的人數將從 2020 年的 7,834,000 人增加 91.16% 至 14,968,000 人。因此,慢性病盛行率的上升是胸骨閉合器市場的主要驅動力。
心血管疾病的日益普及預計將推動胸骨閉合系統市場的發展。許多心血管疾病都需要手術治療,而手術又需要打開胸骨。胸骨閉合系統有助於在手術後有效地閉合胸骨。例如,美國心臟學會發布的一項研究預測,2025年至2060年間,中風風險將增加33.8%,使1,500萬人死亡。此外,在同一時期,心臟衰竭的風險預計將增加33.4%,使1,300萬人死亡;心臟病的風險預計將增加30.7%,使2,900萬人死亡;心臟病發作的風險預計將增加1,600萬人,即增加16.9%。因此,心血管疾病的日益普及正在推動胸骨閉合系統市場的發展。
預計老年人口的成長將推動胸骨閉合器市場的成長。 65歲及以上的老年人口易發生胸骨併發症,例如胸骨撕脫(手術後胸骨分離)。加強型胸骨閉合系統已被證明對接受心臟直視手術的老年患者有效且安全。根據世界衛生組織 (WHO) 2022年10月的報告,到2030年,全球六分之一的人將年滿60歲或以上。預計到2050年,全球60歲以上人口將翻倍,達到21億人。此外,2020年至2050年間,80歲以上人口將增加4.26億。因此,不斷成長的老年人口是胸骨閉合器市場成長的主要驅動力。
為了提升客戶服務,主要企業正在對胸骨閉合器市場的公司進行策略性投資。這些投資使企業能夠開發和推出創新的胸骨閉合系統,增強其競爭地位,並推動市場發展。例如,2022年2月,德國特種化學品公司贏創投資了美國新興企業CircumFix Solutions,該公司開發了一種新型胸骨閉合裝置,以促進患者在心臟直視手術後的康復。這款取得專利的整形外科裝置由贏創的高性能聚合物製成,可在手術後牢固地閉合和固定胸骨。這項投資符合贏創加強其在美國整形外科市場的影響力並支持植入式醫療設備從金屬過渡到高性能聚合物的策略。這款創新的胸骨閉合裝置有望改善患者的復原和安全性,這清楚地表明了贏創致力於推進醫療技術和改善患者預後的承諾。
產品創新已成為胸骨閉合系統市場的關鍵趨勢。為了保持競爭力,主要企業正在推出新產品,例如Valkyrie胸骨環狀縫線。例如,2023年1月,美國心胸外科產品製造商Able Medical Devices推出了專為心血管手術設計的Valkyrie胸骨環狀縫線。此縫合線由不銹鋼製成,採用環形金屬絲設計,方便開胸手術後胸骨閉合。作為Able Medical改善胸腔外科手術效果策略的一部分,Valkyrie縫合線可提供可靠的胸骨閉合,並在癒合過程中提供穩定性和支撐。
胸骨閉合系統市場的主要公司包括 Zimmer Biomet、強生、B. Braun Melsungen AG、Depuy Synthes、KLS Martin Group、Medtronic PLC、A&E Medical Corporation、Stryker Corporation、Kinamed Incorporated、Acumed LLC、Peters Surgical、Orthofix Medical Inc.、Praen Medical. Medical Appliance Co.Ltd.、GPC Medical、Ulrich GmbH & Co.KG、Biomet Microfixation、Idea SRL、Dispomedica GmbH、Scanlan International Inc.、ELLA-CS, sro、Praesidia SRL、Teleflex Incorporated、Invibio Biomaterial Solutions、Eag-Medical Inc.St.
2024年,胸骨閉合系統市場規模最大的地區是北美洲。根據全球胸骨閉合系統市場報告,預測期內,亞太地區預計將成為成長最快的地區。胸骨閉合系統市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。
胸骨閉合系統市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。
胸骨閉合系統市場涵蓋胸骨閉合手術中使用的導線、鉤和油灰的銷售。此市場的價值是指“出廠價”,即商品製造商或生產商向其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。
A sternal closure system is a medical device or method employed to securely close the sternum, the central bone in the chest that safeguards the heart and lungs. These systems play a crucial role in closing the chest, which may be opened during heart surgeries or other procedures requiring access to the chest cavity.
The primary product types of sternal closure systems encompass closure devices, bone cement, and are utilized in procedures such as median sternotomy, hemisternotomy, bilateral thoracosternotomy, among others. Sternal closure devices are specifically designed to hold the sternum together during the healing process, reducing the risk of complications and promoting a faster recovery. These devices find application in closing the sternum, or breastbone, following open-heart surgery. Common materials used in sternal closure systems include titanium, polyether ether ketone (PEEK), stainless steel, and others. The system is utilized by various healthcare facilities, including hospitals and clinics, research institutes, and other medical settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The sternal closure system market research report is one of a series of new reports from The Business Research Company that provides sternal closure system market statistics, including sternal closure system industry global market size, regional shares, competitors with a sternal closure system market share, detailed sternal closure system market segments, market trends and opportunities, and any further data you may need to thrive in the sternal closure system industry. This sternal closure system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sternal closure systems market size has grown steadily in recent years. It will grow from $2.34 billion in 2024 to $2.43 billion in 2025 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to rise in cardiovascular surgeries, prevalence of cardiovascular diseases, increasing awareness of sternal complications, collaboration between surgeons and device manufacturers, focus on minimally invasive cardiac procedures.
The sternal closure systems market size is expected to see strong growth in the next few years. It will grow to $3.07 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to rapid growth in minimally invasive surgery, increased focus on patient-centric healthcare, expansion of cardiac surgery in emerging markets, focus on reducing postoperative complication, collaboration in research and development. Major trends in the forecast period include technological innovations in device materials, technological advancements in surgical techniques, minimally invasive approaches, sternum fixation technologies, wireless remote monitoring, customization and patient-specific solutions.
The forecast of 6.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for critical components like titanium plating systems and sternal wire alloys, sourced from key regions such as Sweden, Belgium, and Singapore, which could lead to surgical delays and increased costs for cardiac procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated growth in the sternal closure market is expected to be driven by the rising incidence of chronic diseases. Chronic diseases, characterized by lasting for a year or longer and demanding continuous medical care, often require surgical interventions such as coronary artery bypass grafting (CABG) or valve replacement. Given that these surgeries involve sternal incisions, the importance of effective sternal closure becomes crucial. For instance, a report from the National Institutes of Health (NIH) predicts a 99.5% increase in the number of people aged 50 and older with at least one chronic illness in the United States, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity is projected to rise by 91.16%, from 7.8304 million in 2020 to 14.968 million in 2050. Hence, the growing incidence of chronic diseases is a key driver for the sternal closure market.
A higher prevalence of cardiovascular diseases is expected to propel the sternal closure system market. Many cardiovascular conditions necessitate surgery, during which the sternum bone must be opened. The sternal closure system proves valuable in effectively closing the sternum following such surgeries. For example, research published by the American College of Cardiology indicates a projected 33.8% increase in the risk of stroke to 15 million individuals from 2025 to 2060. Additionally, during the same period, the risk of heart failure is expected to rise by 33.4% to 13 million individuals, heart disease by 30.7% to 29 million individuals, and heart attack by 16.9% to 16 million individuals. Consequently, the heightened prevalence of cardiovascular diseases is a driving force behind the sternal closure system market.
The expected growth in the sternal closure market is anticipated to be fueled by the increasing geriatric population. The geriatric population, comprising individuals aged 65 and older, is more susceptible to sternal complications, such as sternal dehiscence (the separation of the sternum after surgery). The utilization of reinforced sternal closure systems has proven effective and safe in elderly patients undergoing open-heart surgery. According to a report from the World Health Organization (WHO) in October 2022, one in six individuals worldwide will be 60 years or older by 2030. The global population of individuals over 60 is projected to double to 2.1 billion by 2050. Additionally, between 2020 and 2050, there will be an increase of 426 million people aged 80 or older. Consequently, the rising geriatric population is a significant driver for the growth of the sternal closure market.
Major companies are making strategic investments in firms operating in the sternal closure market to enhance customer service. These investments empower companies to develop and introduce innovative sternal closure systems, strengthening their competitive position and propelling market growth. For example, in February 2022, Evonik, a Germany-based specialty chemicals company, invested in CircumFix Solutions, a US-based start-up that developed a new sternal closure device to enhance patient recovery after open-chest surgery. The patented orthopedic device, composed of a high-performance polymer from Evonik, securely closes and holds the sternum together after surgery. This investment aligns with Evonik's strategy to bolster its presence in the U.S. orthopedic market and support the shift from metal to high-performance polymers in implantable medical devices. The innovative sternal closure device is anticipated to improve patient recovery and safety, underscoring Evonik's commitment to advancing medical technology and enhancing patient outcomes.
Product innovations are emerging as a key trend in the sternal closure system market. Leading companies are introducing new products, such as Valkyrie Looped Sternotomy Sutures, to maintain their competitive edge. For example, in January 2023, Able Medical Devices, a US-based manufacturer of cardiothoracic products, launched the Valkyrie Looped Sternotomy Sutures, designed specifically for heart surgeries. Constructed from stainless steel, these sutures feature a looped wire design to facilitate sternum closure after open-heart procedures. As part of Able Medical's strategy to enhance thoracic surgery outcomes, the Valkyrie sutures provide dependable sternum approximation, offering stability and support during the healing process.
Major companies operating in the sternal closure systems market include Zimmer Biomet, Johnson & Johnson, B. Braun Melsungen AG, Depuy Synthes, KLS Martin Group, Medtronic PLC, A&E Medical Corporation, Stryker Corporation, Kinamed Incorporated, Acumed LLC, Peters Surgical, Orthofix Medical Inc., Praesidia SRL, Waston Medical, ABYRX Inc., Jeil Medical Corporation, Jace Medical, Changzhou Waston Medical Appliance Co. Ltd., GPC Medical, Ulrich GmbH & Co. KG, Biomet Microfixation, Idear SRL, Dispomedica GmbH, Scanlan International Inc., ELLA-CS, s.r.o., Praesidia SRL, Teleflex Incorporated, Invibio Biomaterial Solutions, Eagle BioMedical Inc., Z-Medical GmbH & Co. KG
North America was the largest region in the sternal closure system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sternal closure system market report during the forecast period. The regions covered in the sternal closure systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the sternal closure systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The sternal closure system market consists of sales of wires, hooks, and putty that are used for sternal closure procedures. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sternal Closure Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sternal closure systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for sternal closure systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sternal closure systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.